{"id":"https://openalex.org/W4361950809","doi":"https://doi.org/10.1158/1078-0432.c.6521723.v1","title":"Data from A Phase I Study of Quisinostat (JNJ-26481585), an Oral Hydroxamate Histone Deacetylase Inhibitor with Evidence of Target Modulation and Antitumor Activity, in Patients with Advanced Solid Tumors","display_name":"Data from A Phase I Study of Quisinostat (JNJ-26481585), an Oral Hydroxamate Histone Deacetylase Inhibitor with Evidence of Target Modulation and Antitumor Activity, in Patients with Advanced Solid Tumors","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361950809","doi":"https://doi.org/10.1158/1078-0432.c.6521723.v1"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.c.6521723.v1","doi":"https://doi.org/10.1158/1078-0432.c.6521723.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.6521723.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1078-0432.c.6521723.v1","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5102490416","display_name":"Balaji Venugopal","orcid":"https://orcid.org/0000-0002-0459-7102","observed_orcids":["https://orcid.org/0000-0002-0459-7102"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Balaji Venugopal","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080215197","display_name":"Richard D. Baird","orcid":"https://orcid.org/0000-0001-7071-6483","observed_orcids":["https://orcid.org/0000-0001-7071-6483"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Richard Baird","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088144652","display_name":"Rebecca Sophie Kristeleit","orcid":"https://orcid.org/0000-0003-3825-1326","observed_orcids":["https://orcid.org/0000-0003-3825-1326"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rebecca S. Kristeleit","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048419838","display_name":"Ruth Plummer","orcid":"https://orcid.org/0000-0003-0107-1444","observed_orcids":["https://orcid.org/0000-0003-0107-1444"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ruth Plummer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091827101","display_name":"Richard Andrew Cowan","orcid":"https://orcid.org/0000-0001-9004-8136","observed_orcids":["https://orcid.org/0000-0001-9004-8136"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Richard Cowan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107849323","display_name":"Adam Stewart","orcid":"https://orcid.org/0009-0009-9508-051X","observed_orcids":["https://orcid.org/0009-0009-9508-051X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Adam Stewart","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091647517","display_name":"Nele Fourneau","orcid":"https://orcid.org/0009-0000-9329-0649","observed_orcids":["https://orcid.org/0009-0000-9329-0649"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nele Fourneau","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009980783","display_name":"Peter Hellemans","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Peter Hellemans","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112511359","display_name":"Yusri Ali Elsayed","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yusri Elsayed","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033178457","display_name":"Steve Mcclue","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Steve Mcclue","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010357961","display_name":"Johan Willem Smit","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Johan W. Smit","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103215043","display_name":"Ann Forslund","orcid":"https://orcid.org/0000-0001-6205-2269","observed_orcids":["https://orcid.org/0000-0001-6205-2269"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ann Forslund","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058503646","display_name":"Charles E. Phelps","orcid":"https://orcid.org/0000-0002-4533-0682","observed_orcids":["https://orcid.org/0000-0002-4533-0682"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Charles Phelps","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012637936","display_name":"A. John Camm","orcid":"https://orcid.org/0000-0002-2536-2871","observed_orcids":["https://orcid.org/0000-0002-2536-2871"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John Camm","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038656790","display_name":"Thomas R. Jeffry Evans","orcid":"https://orcid.org/0000-0002-4175-914X","observed_orcids":["https://orcid.org/0000-0002-4175-914X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T.R. Jeffry Evans","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072378199","display_name":"Johann Sebastian De Bono","orcid":"https://orcid.org/0000-0002-2034-595X","observed_orcids":["https://orcid.org/0000-0002-2034-595X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Johann S. de Bono","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5032401979","display_name":"Udai Banerji","orcid":"https://orcid.org/0000-0003-1503-3123","observed_orcids":["https://orcid.org/0000-0003-1503-3123"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Udai Banerji","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11736","display_name":"Histone Deacetylase Inhibitors Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11736","display_name":"Histone Deacetylase Inhibitors Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10269","display_name":"Epigenetics and DNA Methylation","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/quisinostat","display_name":"quisinostat","score":0.9990000128746033},{"id":"https://openalex.org/keywords/histone-deacetylase-inhibitors","display_name":"histone deacetylase inhibitors","score":0.847000002861023},{"id":"https://openalex.org/keywords/hydroxamate","display_name":"hydroxamate","score":0.8989999890327454},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.8040000200271606},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.972000002861023},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9490000009536743},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.9919999837875366},{"id":"https://openalex.org/keywords/histone-acetylation","display_name":"histone acetylation","score":0.8159999847412109},{"id":"https://openalex.org/keywords/ki-67","display_name":"Ki-67","score":0.9470000267028809},{"id":"https://openalex.org/keywords/intermittent-dosing","display_name":"intermittent dosing","score":0.859000027179718},{"id":"https://openalex.org/keywords/advanced-solid-tumors","display_name":"advanced solid tumors","score":0.7699999809265137},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.8730000257492065},{"id":"https://openalex.org/keywords/cardiotoxicity","display_name":"cardiotoxicity","score":0.7160000205039978},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.7509999871253967}],"concepts":[{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.7645530700683594},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6662431955337524},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6455082297325134},{"id":"https://openalex.org/C2777260799","wikidata":"https://www.wikidata.org/wiki/Q15637420","display_name":"Lethargy","level":2,"score":0.5657167434692383},{"id":"https://openalex.org/C2780852908","wikidata":"https://www.wikidata.org/wiki/Q127076","display_name":"Vomiting","level":2,"score":0.5431635975837708},{"id":"https://openalex.org/C2776202225","wikidata":"https://www.wikidata.org/wiki/Q3569101","display_name":"Histone deacetylase inhibitor","level":5,"score":0.5039741396903992},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.47624993324279785},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.461570143699646},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4530363976955414},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.440085232257843},{"id":"https://openalex.org/C76318530","wikidata":"https://www.wikidata.org/wiki/Q16833590","display_name":"Area under the curve","level":2,"score":0.41691672801971436},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3282606303691864},{"id":"https://openalex.org/C2778305200","wikidata":"https://www.wikidata.org/wiki/Q174378","display_name":"Histone deacetylase","level":4,"score":0.29013046622276306},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.1864440143108368},{"id":"https://openalex.org/C64927066","wikidata":"https://www.wikidata.org/wiki/Q36293","display_name":"Histone","level":3,"score":0.06697684526443481},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1078-0432.c.6521723.v1","doi":"https://doi.org/10.1158/1078-0432.c.6521723.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.6521723.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.c.6521723.v1","doi":"https://doi.org/10.1158/1078-0432.c.6521723.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.6521723.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.7200000286102295}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2169690426","https://openalex.org/W1521768634","https://openalex.org/W1942946725","https://openalex.org/W2588745702","https://openalex.org/W4361959270","https://openalex.org/W2097589930","https://openalex.org/W2142629029","https://openalex.org/W2592774280","https://openalex.org/W2273779204","https://openalex.org/W2564351495"],"abstract_inverted_index":{"Abstract":[0],"Purpose:":[1],"To":[2],"determine":[3],"the":[4,146,233,242,253],"maximum-tolerated":[5],"dose":[6,244],"(MTD),":[7],"dose-limiting":[8],"toxicities":[9],"(DLT),":[10],"and":[11,13,70,73,79,97,113,126,133,143,168,171,184,239],"pharmacokinetic":[12,237],"pharmacodynamic":[14,240],"profile":[15,214],"of":[16,151,215,221,235],"quisinostat,":[17],"a":[18,49],"novel":[19],"hydroxamate,":[20],"pan-histone":[21],"deacetylase":[22],"inhibitor":[23],"(HDACi).":[24],"Experimental":[25],"Design:":[26],"In":[27],"this":[28],"first-in-human":[29],"phase":[30,246],"I":[31],"study,":[32],"quisinostat":[33,152,216],"was":[34,193,202,217],"administered":[35],"orally,":[36],"once":[37],"daily":[38,94],"in":[39,92,164,172,182,195,204],"three":[40,98],"weekly":[41],"cycles":[42],"to":[43],"patients":[44,89,206],"with":[45,155,198,219],"advanced":[46],"malignancies,":[47],"using":[48],"two-stage":[50],"accelerated":[51],"titration":[52],"design.":[53],"Three":[54],"intermittent":[55,99],"schedules":[56,101,225],"were":[57,82,90,117,131,226],"subsequently":[58],"explored:":[59],"four":[60],"days":[61,63],"on/three":[62],"off;":[64],"every":[65,71],"Monday,":[66],"Wednesday,":[67],"Friday":[68],"(MWF);":[69],"Monday":[72],"Thursday":[74],"(M-Th).":[75],"Toxicity,":[76],"pharmacokinetics,":[77],"pharmacodynamics,":[78],"clinical":[80],"efficacy":[81],"evaluated":[83],"at":[84],"each":[85],"schedule.":[86,255],"Results:":[87],"Ninety-two":[88],"treated":[91],"continuous":[93,230],"(2\u201312":[95],"mg)":[96],"dosing":[100],"(6\u201319":[102],"mg).":[103],"Treatment-emergent":[104],"adverse":[105,212],"events":[106],"included:":[107],"fatigue,":[108],"nausea,":[109],"decreased":[110,180],"appetite,":[111],"lethargy,":[112],"vomiting.":[114],"DLTs":[115,130],"observed":[116],"predominantly":[118],"cardiovascular,":[119],"including":[120],"nonsustained":[121],"ventricular":[122],"tachycardia,":[123],"ST/T-wave":[124],"abnormalities,":[125],"other":[127,222],"tachyarhythmias.":[128],"Noncardiac":[129],"fatigue":[132],"abnormal":[134],"liver":[135],"function":[136],"tests.":[137],"The":[138,211],"maximum":[139],"plasma":[140,147],"concentration":[141],"(Cmax)":[142],"area":[144],"under":[145],"concentration\u2013time":[148],"curve":[149],"(AUC)":[150],"increased":[153,160],"proportionally":[154],"dose.":[156],"Pharmacodynamic":[157],"evaluation":[158],"showed":[159],"acetylated":[161],"histone":[162],"3":[163],"hair":[165],"follicles,":[166],"skin":[167,183],"tumor":[169,185],"biopsies,":[170],"peripheral":[173],"blood":[174],"mononuclear":[175],"cells":[176],"as":[177,179],"well":[178],"Ki67":[181],"biopsies.":[186],"A":[187],"partial":[188],"response":[189],"lasting":[190],"five":[191],"months":[192],"seen":[194,203],"one":[196],"patient":[197],"melanoma.":[199],"Stable":[200],"disease":[201],"eight":[205],"(duration":[207],"4\u201310.5":[208],"months).":[209],"Conclusions:":[210],"event":[213],"comparable":[218],"that":[220],"HDACi.":[223],"Intermittent":[224],"better":[227],"tolerated":[228],"than":[229],"schedules.":[231],"On":[232],"basis":[234],"tolerability,":[236],"predictions,":[238],"effects,":[241],"recommended":[243],"for":[245],"II":[247],"studies":[248],"is":[249],"12":[250],"mg":[251],"on":[252],"MWF":[254],"Clin":[256],"Cancer":[257],"Res;":[258],"19(15);":[259],"4262\u201372.":[260],"\u00a92013":[261],"AACR.":[262]},"counts_by_year":[],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2023-04-05T00:00:00"}